Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios Are Associated with Recurrent Ischemic Stroke in Patients with Embolic Stroke of Undetermined Source.
作者信息
Li Tony Y W, Sia Ching-Hui, Chan Bernard P L, Ho Jamie S Y, Leow Aloysius S, Chan Mark Y, Kojodjojo Pipin, Galupo Mary Joyce, Teoh Hock-Luen, Sharma Vijay K, Seet Raymond C S, Yeo Leonard L L, Tan Benjamin Yong-Qiang
机构信息
Department of Cardiology, National University Heart Centre Singapore, Singapore.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
出版信息
J Stroke. 2022 Sep;24(3):421-424. doi: 10.5853/jos.2022.00486. Epub 2022 Sep 30.
Abstract
摘要
相似文献
1
Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios Are Associated with Recurrent Ischemic Stroke in Patients with Embolic Stroke of Undetermined Source.
J Stroke. 2022 Sep;24(3):421-424. doi: 10.5853/jos.2022.00486. Epub 2022 Sep 30.
2
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
JAMA Neurol. 2020 Oct 1;77(10):1233-1240. doi: 10.1001/jamaneurol.2020.1995.
3
Changes in neutrophil, lymphocyte, platelet ratios and their relationship with NIHSS after rtPA and/or thrombectomy in ischemic stroke.
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):105004. doi: 10.1016/j.jstrokecerebrovasdis.2020.105004. Epub 2020 Jun 14.
4
Anticoagulation and Risk of Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source Having No Potential Source of Embolism.
Cerebrovasc Dis. 2020;49(6):601-608. doi: 10.1159/000510773. Epub 2020 Nov 11.
5
Characteristics and prognosis of patients with embolic stroke of undetermined source in China.
Int J Stroke. 2022 Jun;17(5):526-535. doi: 10.1177/17474930211028040. Epub 2021 Jul 2.
6
Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design.
Int J Stroke. 2017 Dec;12(9):985-990. doi: 10.1177/1747493016681019. Epub 2016 Nov 23.
7
Emerging Risk Factors for Recurrent Vascular Events in Patients With Embolic Stroke of Undetermined Source.
Stroke. 2016 Nov;47(11):2714-2721. doi: 10.1161/STROKEAHA.116.013878. Epub 2016 Oct 4.
8
Clot composition of embolic strokes of undetermined source: a feasibility study.
BMC Neurol. 2020 Oct 21;20(1):383. doi: 10.1186/s12883-020-01969-w.
9
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.
10
d-dimer Level as a Predictor of Recurrent Stroke in Patients With Embolic Stroke of Undetermined Source.
Stroke. 2021 Jul;52(7):2292-2301. doi: 10.1161/STROKEAHA.120.033217. Epub 2021 May 11.
引用本文的文献
1
A Nomogram for Predicting the Recurrence of Acute Non-Cardioembolic Ischemic Stroke: A Retrospective Hospital-Based Cohort Analysis.
Brain Sci. 2023 Jul 10;13(7):1051. doi: 10.3390/brainsci13071051.
2
Towards a biomarker for acute arterial thrombosis using complete blood count and white blood cell differential parameters in mice.
Sci Rep. 2023 Mar 10;13(1):4043. doi: 10.1038/s41598-023-31122-9.
3
Predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation and stroke in type 2 diabetes mellitus: The Hong Kong Diabetes Study.
Endocrinol Diabetes Metab. 2023 Jan;6(1):e397. doi: 10.1002/edm2.397. Epub 2022 Dec 4.
本文引用的文献
1
The neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict left ventricular thrombus resolution in acute myocardial infarction without percutaneous coronary intervention.
Thromb Res. 2020 Oct;194:16-20. doi: 10.1016/j.thromres.2020.06.003. Epub 2020 Jun 3.
2
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.
N Engl J Med. 2019 Dec 26;381(26):2497-2505. doi: 10.1056/NEJMoa1912388. Epub 2019 Nov 16.
3
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.
4
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.
5
Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio as Risk Factors for Venous Thrombosis.
Clin Appl Thromb Hemost. 2018 Jul;24(5):808-814. doi: 10.1177/1076029617733039. Epub 2017 Oct 31.
6
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
7
Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update.
Stroke. 2017 Apr;48(4):867-872. doi: 10.1161/STROKEAHA.116.016414. Epub 2017 Mar 6.
8
Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.
Lancet Neurol. 2015 Apr;14(4):377-87. doi: 10.1016/S1474-4422(15)70027-X. Epub 2015 Mar 4.
9
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70. doi: 10.1093/ehjci/jev014.
10
Anti-inflammatory therapeutics for the treatment of atherosclerosis.
Nat Rev Drug Discov. 2011 May;10(5):365-76. doi: 10.1038/nrd3444.
Zotero 插件